This inventor holds 1 USPTO granted patent. Top assignees: Institut Pasteur, National Institute of Health and Medical Research. Active years: 1999.
Company Filing History:
1 out of 897 
1 out of 1,853 
Years Active: 1999
Title: Michele Longuet: Innovator in Human Papillomavirus Research
Introduction
Michele Longuet is a notable inventor based in Palaiseau, France. He has made significant contributions to the field of virology, particularly in the study of human papillomavirus (HPV). His work has implications for understanding and potentially combating oncogenic viruses.
Latest Patents
Michele Longuet holds a patent related to Genital human papillomavirus type 68a (HPV-68a). This patent involves the genomes of two novel HPV types, HPV68 and HPV70, which were cloned from a low-grade cervical intraepithelial neoplasia and a vulvar papilloma, respectively. Both types are related to HPV39, a potentially oncogenic virus. His research indicates that HPV68 and HPV70 were detected in genital intraepithelial neoplasia from multiple patients. The comparison with existing sequence data suggests that the subgenomic ME180-HPV DNA fragment corresponds to an HPV68 subtype, highlighting the global distribution of variants of HPV68 and HPV70.
Career Highlights
Throughout his career, Michele Longuet has worked with prestigious institutions such as the Institut Pasteur and the National Institute of Health and Medical Research. His research has contributed to the understanding of HPV and its variants, which is crucial for public health.
Collaborations
Michele Longuet has collaborated with notable colleagues, including Gerard Orth and Sylvie Beaudenon. Their combined expertise has furthered research in the field of HPV and its implications for human health.
Conclusion
Michele Longuet's work in HPV research exemplifies the importance of innovation in understanding viral diseases. His contributions through patents and collaborations continue to impact the field significantly.